Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vicarious Surgical has developed a next-generation single-port robotic surgery system designed to enable minimally invasive procedures through a single small incision. The company’s proprietary technology features human-like robotic arms with high dexterity and immersive visualization. As of mid 2025, the company has received FDA Breakthrough Device Designation and plans to begin first-in-human clinical use in partnership with UMass Memorial Medical Center during 2025, targeting ventral hernia repair as its initial indication. No commercial sales or pivotal trial results have been reported yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vicarious Surgical.